Target proteins of ganoderic acid DM provides clues to various pharmacological mechanisms

Scientific Reports

Volumn 2, Issue , 2012, Pages

  Liu, Jie ^a,b   Shimizu, Kuniyoshi ^a   Tanaka, Akinobu ^a   Shinobu, Wakako ^e   Ohnuki, Koichiro ^c   Nakamura, Takanori ^d   Kondo, Ryuichiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c KYUSHU NUTRITION WELFARE UNIVERSITY   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e NIHON DEMPA KOGYO CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GANODERIC ACID; HERBACEOUS AGENT; TRITERPENE; TUBULIN; TUBULIN MODULATOR; VINBLASTINE;

ARTICLE; CELL FRACTIONATION; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; GANODERMA; GANODERMA LUCIDUM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOLATION AND PURIFICATION; KINETICS; MALE; METABOLISM; PROTEIN BINDING; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL FRACTIONATION; CELL LINE, TUMOR; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUGS, CHINESE HERBAL; GANODERMA; HUMANS; KINETICS; MALE; PROTEIN BINDING; STRUCTURE-ACTIVITY RELATIONSHIP; TRITERPENES; TUBULIN; TUBULIN MODULATORS; VINBLASTINE;

EID: 84870812158     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00905     Document Type: Article

References (23)

1. Lin, C. N., Tome, W. P. & Won, S. J. Novel cytotoxic principles of Formosan Ganoderma lucidum. J. Nat. Prod. 54, 998-1002 (1991).
2. Iwatsuki, K. et al. Lucidenic acids P and Q, methyl lucidenate P, and other triterpenoids from fungus Ganoderma lucidum and their inhibitory effects on Epstein-barr virus activation. J. Nat. Prod. 66, 1582-1585 (2003). (Pubitemid 38036711)
3. Shiao, M. S. Natural products of the medicinal fungus Ganoderma lucidum: occurrence, biological activities, and pharmacological functions. Chem. Rec. 3, 172-180 (2003).
4. De Silva, D. D., Rapior, S., Hyde, K. D. & Bahkali, A. H. Medicinal mushrooms in prevention and control of diabetes mellitus. Fungal Divers. 56, 1-29 (2012).
5. Kohda, H. et al. The biologically active constituents of Ganoderma lucidum histamine release-inhibitory triterpenes. Chem. Pharm. Bull. 33, 1367-1374 (1985). (Pubitemid 15048664)
6. Morigiwa, A., Kitabatake, K., Fujimoto, Y. & Ikekawa, N. Angiotensin converting enzyme, inhibiting triterpenes from Ganoderma lucidum. Chem. Pharm. Bull. 34, 3025-3028 (1986). (Pubitemid 16001863)
7. Komoda, Y., Shimizu, M., Sonoda, Y. & Sato, Y. Ganoderic acid and its derivatives as cholesterol synthesis inhibitors. Chem. Pharm. Bull. 37, 531-533 (1989). (Pubitemid 19082605)
8. Cao, Y., Wu, S. H. & Dai, Y. C. Species clarification of the prize medicinal Ganoderma mushroom "Lingzhi". Fungal Divers. 56, 49-62 (2012).
9. Liu, J., Kurashiki, K., Shimizu, K. & Kondo, R. 5a-reductase inhibitory effects of triterpenoids isolated from Ganoderma lucidum. Biol. Pharm. Bull. 29, 392-395 (2005).
10. Fujita, R. et al. Anti-androgenic activities of Ganoderma lucidum. J. Ethnopharmacol. 102, 107-112 (2005). (Pubitemid 41375944)
11. Liu, J. et al. Anti-androgen effects of extracts and compounds from Ganoderma lucidum. Chem. Biodiversity. 6, 231-243 (2009).
12. Shimizu, K. et al. Estrogen-like activity of ethanol extract of Ganoderma lucidum. J. Wood Sci. 55, 53-59 (2009).
13. Liu, J., Shiono, J., Shimizu, K. & Kondo, R. Ganoderic acids from Ganoderma lucidum. Inhibitory activity of osteoclastic differentiation and structural criteria. Planta Med. 76, 137-139 (2010).
14. Liu, J. et al. Ganoderic acid DM: anti-androgenic osteoclastogenesis inhibitor. Bioorg. Med. Chem. Lett. 19, 2154-2157 (2009).
15. Yue, Q. X. et al. Proteomics characterization of the cytotoxicity mechanism of ganoderic acid D and computer-automated estimation of the possible drug target network. Mol. Cell Proteomics 7, 949-961 (2008).
16. Yue, Q. X. et al. Effects of triterpenes from Ganoderma lucidum on protein expression profile of Hela cells. Phytomedicine 17, 606-613 (2010).
17. Wu, G. S. et al. Ganoderic acid DM, a natural triterpenoid, induces DNA damage, G1 cell cycle arrest and apoptosis in human breast cancer cells. Fitoterapia 83(2), 408-414 (2012).
18. Jordan, M. A. & Wilson L. Microtubules as a target for anticancer drugs. Nat. Rev. Cancer 4, 253-256 (2004).
19. Kingston, D. G. I. Tubulin-interactive natural products as anticancer agents (1). J. Nat. Prod. 72(3), 507-515 (2009).
20. Muto, T., Watanabe, S., Wakamatsu, S. & Koyama, M. Examination for realization of a high precision crystal sensor. IEEE IFCS 2, 532-534 (2008).
21. Mizutani, N., Korposh, S., Selyanchyn, R., Wakamatsu, S. & Lee, S. W. Application of a quartz crystal microbalance (QCM) twin sensor for selective label-free immunoassay to simultaneous antigen-antibody reactions. Sensors & Transducers 137, 1-9 (2012).
22. Ersoa, A., Diltemiz, S. E., Ozcan, A. A., Denizli, A. & Say, R. Synergie between molecular imprinted polymer based on solid-phase extraction and quartz crystal microbalance technique for 8-OHdG sensing. Biosens Bioelectron 24, 742-747 (2008).
23. Bonne, D., Heusele, C., Simon, C. & Pantaloni, D. 49, 6-Diamidino-2-phenylindole, a fluorescent probe for tubulin and microtubules. J. Biol. Chem. 260, 2819-2825 (1985). (Pubitemid 15141425)